Semisynthetic Pneumococcal Glycoconjugate Nanovaccine.


Journal

Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319

Informations de publication

Date de publication:
20 09 2023
Historique:
medline: 21 9 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

Pneumococcal conjugate vaccines offer an excellent safety profile and high protection against the serotypes comprised in the vaccine. However, inclusion of protein antigens from

Identifiants

pubmed: 37694903
doi: 10.1021/acs.bioconjchem.3c00252
pmc: PMC10515484
doi:

Substances chimiques

Chitosan 9012-76-4
Pneumococcal Vaccines 0
Adjuvants, Immunologic 0
Glycoconjugates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1563-1575

Références

Semin Immunol. 2017 Dec;34:78-102
pubmed: 29032891
J Immunol Res. 2017;2017:9125048
pubmed: 28758135
J Control Release. 2001 Sep 11;76(1-2):59-71
pubmed: 11532313
Drug Deliv Transl Res. 2021 Apr;11(2):581-597
pubmed: 33655441
Drug Deliv. 2016;23(1):185-94
pubmed: 24825494
J Control Release. 1998 Apr 30;53(1-3):215-24
pubmed: 9741929
Pharm Res. 1999 Oct;16(10):1576-81
pubmed: 10554100
Jpn J Infect Dis. 2011;64(6):451-7
pubmed: 22116322
Infect Immun. 2005 Feb;73(2):1006-13
pubmed: 15664944
J Pharm Pharmacol. 2008 Dec;60(12):1591-600
pubmed: 19000363
Vaccine. 2007 Mar 1;25(11):2085-94
pubmed: 17258843
Vaccine. 2011 May 23;29(23):3982-9
pubmed: 21481328
Heliyon. 2017 Apr 11;3(4):e00291
pubmed: 28435909
Nanotechnology. 2017 Apr 21;28(16):165101
pubmed: 28206982
Mucosal Immunol. 2019 Jul;12(4):1055-1064
pubmed: 30953000
Infect Immun. 2012 Jan;80(1):461-8
pubmed: 22025519
Pharm Biotechnol. 2002;14:281-360
pubmed: 12189727
Clin Microbiol Rev. 2015 Jul;28(3):871-99
pubmed: 26085553
Infect Immun. 2002 Oct;70(10):5363-9
pubmed: 12228260
Int Immunopharmacol. 2018 Aug;61:385-393
pubmed: 29945026
J Immunol. 2011 May 15;186(10):5590-602
pubmed: 21490153
J Clin Microbiol. 2000 Jan;38(1):434-7
pubmed: 10618136
J Colloid Interface Sci. 2006 Oct 15;302(2):522-9
pubmed: 16887138
Adv Drug Deliv Rev. 2005 Jan 10;57(3):333-55
pubmed: 15560945
mBio. 2016 Nov 1;7(6):
pubmed: 27803187
Vaccine. 2011 Nov 8;29(48):8965-73
pubmed: 21945255
Infect Immun. 2002 Mar;70(3):1143-9
pubmed: 11854194
Curr Opin Immunol. 2011 Jun;23(3):407-13
pubmed: 21514128
Biomaterials. 2018 Nov;184:1-9
pubmed: 30195140
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):19-31
pubmed: 25149825
Vaccine. 1994 Mar;12(4):299-306
pubmed: 8178550
Scand J Immunol. 2015 Mar;81(3):177-85
pubmed: 25565478
Clin Vaccine Immunol. 2011 Jan;18(1):75-81
pubmed: 21047997
Adv Drug Deliv Rev. 2009 Feb 27;61(2):140-57
pubmed: 19121350
J Colloid Interface Sci. 2005 Mar 15;283(2):344-51
pubmed: 15721903
ACS Infect Dis. 2018 Nov 9;4(11):1553-1563
pubmed: 30180541
Clin Vaccine Immunol. 2014 May;21(5):651-60
pubmed: 24599529
Int J Pharm. 2009 Dec 1;382(1-2):205-14
pubmed: 19660537
Nanomedicine (Lond). 2012 May;7(5):651-62
pubmed: 22630149
Eur J Pharm Sci. 2019 Mar 1;129:31-41
pubmed: 30572107
Vaccine. 2001 May 14;19(25-26):3360-8
pubmed: 11348699
Trends Immunol. 2008 Apr;29(4):186-94
pubmed: 18329338
Crit Rev Clin Lab Sci. 1989;27(1):27-58
pubmed: 2647414
J Immunol. 2005 Sep 1;175(5):3309-17
pubmed: 16116223
Semin Immunol. 2017 Dec;34:25-32
pubmed: 28985993
Drug Deliv Transl Res. 2013 Feb;3(1):100-9
pubmed: 23316448
Eur J Pharm Sci. 2012 Mar 12;45(4):475-81
pubmed: 22009113
Transfusion. 2018 Dec;58 Suppl 3:3106-3113
pubmed: 30536434
Vaccine. 2004 Sep 9;22(27-28):3603-12
pubmed: 15315839
Infect Immun. 2008 Oct;76(10):4615-23
pubmed: 18678667
NPJ Vaccines. 2018 Oct 31;3:53
pubmed: 30393571
Infect Immun. 1997 May;65(5):1967-71
pubmed: 9125591
Vaccine. 2007 Jan 2;25(1):144-53
pubmed: 16973248
Vaccine. 2008 Jun 2;26(23):2925-9
pubmed: 18440673
Immunotherapy. 2014;6(3):309-20
pubmed: 24762075
Sci Rep. 2016 Dec 02;6:38348
pubmed: 27910914
Crit Rev Microbiol. 2008;34(3-4):131-42
pubmed: 18728990
BMC Infect Dis. 2014 Dec 20;14:3862
pubmed: 25527277
Int J Pharm. 2017 Sep 15;530(1-2):128-138
pubmed: 28698066
Pharm Res. 1997 Oct;14(10):1431-6
pubmed: 9358557
J Infect Dis. 2000 Oct;182(4):1146-52
pubmed: 10979911
Vaccine. 2004 Jun 23;22(19):2396-405
pubmed: 15193401
Microb Pathog. 2012 Nov-Dec;53(5-6):243-9
pubmed: 22981893
Vaccine. 2007 Jun 6;25(23):4602-10
pubmed: 17485148

Auteurs

Maruthi Prasanna (M)

Center for Research in Molecular Medicine and Chronic Diseases, Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela 15706, Spain.
Nantes Université, CNRS, Unité des Sciences Biologiques et des Biotechnologies (US2B), UMR 6286, Nantes F-44000, France.
Department of Biochemistry and Molecular Biology, University of Santiago de Compostela, Santiago de Compostela 15706, Spain.

Rubén Varela Calvino (R)

Department of Biochemistry and Molecular Biology, University of Santiago de Compostela, Santiago de Compostela 15706, Spain.

Annie Lambert (A)

Nantes Université, CNRS, Unité des Sciences Biologiques et des Biotechnologies (US2B), UMR 6286, Nantes F-44000, France.

Maria Arista Romero (M)

Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona 08034, Spain.

Sylvia Pujals (S)

Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona 08034, Spain.

François Trottein (F)

Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, Lille F-59000, France.

Emilie Camberlein (E)

Nantes Université, CNRS, Unité des Sciences Biologiques et des Biotechnologies (US2B), UMR 6286, Nantes F-44000, France.

Cyrille Grandjean (C)

Nantes Université, CNRS, Unité des Sciences Biologiques et des Biotechnologies (US2B), UMR 6286, Nantes F-44000, France.

Noemi Csaba (N)

Center for Research in Molecular Medicine and Chronic Diseases, Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela 15706, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH